Meribank Biotech Co (ROCO:4724) EPS (Basic): NT$-0.89 (TTM As of Dec. 2025)


ROCO:4724 Meribank Biotech Co Ltd ROCO:4724
40 GF Score
Price NT$10.10
GF Value NT$48.46
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Meribank Biotech Co EPS (Basic)?

Meribank Biotech Co ROCO:4724 -5.61% 40 EPS (Basic) is NT$-0.89 as of Dec. 2025. GuruFocus rates ROCO:4724 with a GF Score™ of 40/100 and a GF Value™ of NT$48.46 (Possible Value Trap). The stock has 6 warning signs investors should review.

Meribank Biotech Co's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was NT$-0.67. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-0.89.

Meribank Biotech Co's EPS (Diluted) for the six months ended in Dec. 2025 was NT$-0.67. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-0.89.

Meribank Biotech Co's EPS without NRI for the six months ended in Dec. 2025 was NT$-0.65. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was -0.84.

During the past 3 years, the average EPS without NRI Growth Rate was 20.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 3.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Meribank Biotech Co's highest 3-Year average EPS without NRI Growth Rate was 20.10% per year. The lowest was -135.40% per year. And the median was -13.20% per year.

Meribank Biotech Co  (ROCO:4724) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Meribank Biotech Co EPS (Basic) Related Terms

Meribank Biotech Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Meribank Biotech Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Meribank Biotech Co EPS (Basic) Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial -1.63 -1.63 -1.99 -1.19 -0.89

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.04 -0.66 -0.53 -0.22 -0.67
ROCO:4724
40GF Score
Meribank Biotech Co Ltd ROCO:4724
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Meribank Biotech Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Meribank Biotech Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-81.465-0)/91.330
=-0.89

Meribank Biotech Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-62.406-0)/94.684
=-0.66

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NT$-0.89 mean?
Meribank Biotech Co (ROCO:4724) has a EPS (Basic) of NT$-0.89 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Meribank Biotech Co and its competitors.
Is Meribank Biotech Co's EPS (Basic) too high?
Meribank Biotech Co's current EPS (Basic) is NT$-0.89. Overall, Meribank Biotech Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Meribank Biotech Co's EPS (Basic) compare to VRTX and REGN?
Meribank Biotech Co's EPS (Basic) of NT$-0.89 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Meribank Biotech Co and its competitors. Meribank Biotech Co's current EPS (Basic) is NT$-0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Meribank Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Meribank Biotech Co (ROCO:4724) is currently considered Possible Value Trap. The stock's GF Value™ is NT$48.46, compared to a current price of NT$10.10 — trading 79.2% below its estimated fair value. The current EPS (Basic) is NT$-0.89. Meribank Biotech Co's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Meribank Biotech Co (ROCO:4724), the current EPS (Basic) is NT$-0.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Meribank Biotech Co (ROCO:4724) Overvalued in 2026?

Based on GuruFocus' analysis, Meribank Biotech Co stock appears to be undervalued. The current stock price of NT$10.10 is trading 79.2% below its estimated GF Value™ of NT$48.46. GuruFocus considers Meribank Biotech Co to be Possible Value Trap.

Key valuation signals for ROCO:4724:

  • EPS (Basic): NT$-0.89
  • GF Value™: NT$48.46 vs. price of NT$10.10 (79.2% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4724 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Meribank Biotech Co Business Description

Address Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.
40GF Score

Get the complete analysis for ROCO:4724

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.10
Price
NT$48.46
GF Value